Green Light GxP HPLC 2
|
|
- きみのしん あきます
- 5 years ago
- Views:
Transcription
1 Excellence Plus Good Manufacturing Practice (GMP) 1 (OOS) (OOT) (OOE) LevelControl 8 9 profact profact Advanced 9 TestManager
2 Green Light GxP HPLC 2
3 GMP GLP (USP) FDA (PAI) FDA 1 GxP GxP (GMP) (GLP) (USP) GMP GLP GMP [ 1 2] OECD GLP [ 3 4 5] EU GMP 2 [ 6] GMP GMP [ 7 8] [ 9 10] (HPLC ) EU GMP EU GMP 4 [ 11] GMP [ 12] 3
4 Green Light GXP (USP) General Chapter/ Information 3 <41> Balances ; <1251> Weighing on an Analytical Balance ; <1058> Analytical Instrument Qualification. USP Chapter <41> 2 <41> Balances <1251> Weighing on an Analytical Balance [ 13 14] USP Chapter (<1000> ) <1000> <1999> 2 USP <41> USP 10 5% Chapter (AIQ) USP <1058> [ 15] USP <1251> [ 14] USP <1251> ( (DQ) (IQ) (OQ) (PQ) ) [ 14] () 2005 [ 16] FDA 2012 (CPG) [ 17] CMC CDER ( ) CMC CGP CMC / / 4
5 GxP 1 (CRO) (CMO) 2009 FDA post 483 [ 18] GMP DQ IQ OQ ID 5
6 Green Light FDA 1 1 ph API (FDA ) 1 2 < > (FDA ) 3 1 API 500mg (0.5g) 100mg (0.1g) 10mg (0.01g) (FDA ) 1 [ 15] OQ 6
7 4 USP <41> 4 10mg QC ( ) (FDA ) [ 7 15] [ 19] [ 17] CMC / / 7
8 Green Light Excellence XPE / XSE TestManager 2 2 LevelControl Test Manager FACT Advanced profact Advanced LevelControl LevelControl LevelControl TestMananer LIMS ELN LabX Balances SW 8
9 profact profact Advanced FACT Fully Automated Calibration Technology FACT ( 1-3 K ) 2 profact profact Advanced FACT FACT "FACT " "FACT " 3 9
10 Green Light profact Advanced OOS OOT USP Chapter <1251> [ 14] 2 3 Excellence Plus FDA profact profact Advanced FDA [ 20] ( ) FDA profact Advanced OOS profact profact Advanced 10
11 TestManager 1 Excellence XPE XSE TestManager SOP TestManager (E2 F1 ) SOP SOP SOP SOP TestManager TestManager (b)(4) [ 8] Excellence Plus 1-3 K "" "" TestManager / 11
12 1. Current Good Manufacturing Practice for Finished Pharmaceutical Products 21 CFR Current Good Manufacturing Practice for Finished Pharmaceutical Products 21 CFR Good Laboratory Practice for Non-Clinical Studies, 21 CFR and Principles of Good Laboratory Practice, Organisation of Economic Cooperation and Development (OECD), Section 4. Apparatus, Material, and Reagents clauses 1 and 2 5. Good Laboratory Practice, Ordinance 21, Ministry of Health Labour and Welfare Chapter 3 Testing Facilities and Equipment (Equipment), Article EU Good Manufacturing Practice regulations, Chapter 3 Facilities and Equipment, clauses 3.40 and Current Good Manufacturing Practice for Finished Pharmaceutical Products 21 CFR (b) 8. Current Good Manufacturing Practice for Finished Pharmaceutical Products 21 CFR (b)(4) 9. Current Good Manufacturing Practice for Finished Pharmaceutical Products 21 CFR (a) 10. Current Good Manufacturing Practice for Finished Pharmaceutical Products 21 CFR (c) 11. Current Good Manufacturing Practice for Finished Pharmaceutical Products 21 CFR EU Good Manufacturing Practice regulations, Chapter 4, clause United States Pharmacopoeia <41> Weights and Balances, Rockville, Maryland, United States Pharmacopoeia <1251> Weighing on an Analytical Balance, Rockville, Maryland, United States Pharmacopoeia <1058> Analytical Instrument Qualification, Rockville, Maryland, Able Laboratories, FDA Form 483 Observations, July Compliance Program Guide Pre-Approval Inspections published May 2010, effective May FDA Post 483 Inspection Program August GMP (Good Weighing Practice) The Standard, Science Based Weighing, 20. FDA Questions and Answers on Current Good Manufacturing Practices, Good Guidance Practices, Level 2 Guidance Laboratory Controls Guidances/ucm htm#1 (accessed 18 Aug 2013) TEL : FAX: TEL : FAX: sales.admin.jp@mt.com F 09/2013 Mettler-Toledo AG Printed in Switzerland
White Paper 計量プロセスにおける GxP OOS 目次 LabX RFID 11 RFID 11 RFID
計量プロセスにおける GxP OOS 目次 2 2 2 2 2 1 3 4 5 2 5 6 7 3 LabX 7 8 8 3 8 11 RFID 11 RFID 11 RFID 12 13 14 Error Sources HPLC 現在のプロセスフロー : LabX 1 3 LabX 1 1 2 2 3 3 1 プロセス 1: 手作業による計量および記録 1 図 1: 1 台の分析天びんによる手動ワークフロー
More informationContent 50μg5 OIML CarePacs CarePacs 2
OIML Weights WeightLink CarePacs E1 E2 F1 E2 F1 F1 F2 M1 F1 M3 Content 50μg5 OIML 4 6 8 CarePacs CarePacs 2 10 12 14 SI WeightLink 3 Expertise OIML OIML R111 OIMLE1 E2 F1 F2 M1 M2 M3 50μg5 8.0kg/dm 3 4
More information2014-sougou_all.pdf
37 Ministry of Health, Labour and Welfare 2014 38 Ministry of Health, Labour and Welfare 2014 39 Ministry of Health, Labour and Welfare 2014 40 Ministry of Health, Labour and Welfare 2014 Q1 A1 Q2 A2 Q3
More informationコンピュータバリデーション
HP ????????? HP Report 21 CFR Part 11, 1991 1992 1994 1994-1997 100 1997 3 20 : 8 20 1999 FDA 1999 483 Observations and warning letters http://www.fda.gov/cder/esig/index.htm Choose View, Header and Footer
More information( 参考資料 1) US-FDA のシステム (6 システム ) 査察の枠組みについて Page 2 of 5 pages (STRATEGY: 戦略 ) C. A Scheme of Systems for the Manufacture of Drugs/Drug Products 原薬 / 医
( 参考資料 1) US-FDA のシステム (6 システム ) 査察の枠組みについて Page 1 of 5 pages 2017.09. 20 ( 参考資料 1) US-FDA のシステム (6 システム ) 査察の枠組みについて ファルマ ソリューションズ この文書は 米国 FDA が医薬品製造所の GMP 査察を行う場合の査察官用のマニュアルである COMPLIANCE PROGRAM GUIDANCE
More informationuntitled
http://www.ecompliance.co.jp 1.0 2006/05/26 Copyright(C) 2006 ecompliance Ltd. All Rights Reserved. Page 1 1.... 4 2.... 4 3.... 4 3.1... 4 3.2... 4 3.3... 4 3.4... 4 4.... 4 4.1... 4 4.2... 5 4.3... 5
More information橡jisq1500.PDF
JIS Q 15001 JIS Q 15001 105-0011 - - 03-3432-9387 Fax 03-3432-9417 E-mail info-privacy@jipdec.or.jp JIS Q 15001 107-8440 - - 03-3583-8002 Fax 03-3583-0462 JIS Q 15001 : 1999 Requirements for compliance
More information(EQP) (DQ) (IQ) (OQ) OQ (RQ) IQ OQ IQ OQ (ACE) OQ EQP EQP Adobe (i) Q & A (ii) Agilent Compliance Engine (ACE) - 21 CFR Part11 (iii) EE 1.76 EQR 3 PDF
Equipment Qualification Plan (EQP) GC Agilent 7890/7820 (CTC ) Agilent 6890/6850/5890 GC EQP : Agilent_Recommended_EQP_GC (EQP) (DQ) (IQ) (OQ) OQ (RQ) IQ OQ IQ OQ (ACE) OQ EQP EQP Adobe (i) Q & A (ii)
More informationŁ\”ƒ1PDFŠp
73 88 Takeshi MIZUGUCHI This article investigates several studies, proposals and practices regarding environmental accounting and environmental information disclosure. Objects of the investigation include
More information11 11 13 13 13 13 14 14 15 16 16 17 17 17 18 18 21 21 23 24 25 25 26 1 26 27 29 34 34 34 35 35 37 39 41 42 42 43 44 44 44 45 46 46 47 47 48 48 49 50 50 50 51 52 52 53 53 54 55 55 55 55 2 56 57 57 58 59
More information欧州に見るマイナス金利が銀行に及ぼす影響
TEL 3-6733-17 E-mail 1 / 14 216 5 27 TEL 3-6733-17 E-mail 2 / 14 EU 2161 2146 2152 2127 2149 21412 2163 216 3.1%.1%...5%.6% 1.25%.65% CD.75%.5% 1.45% 1.2% 1 (2164 ).82%.97%.62%.51%.259% 3.325% 2161 1 6,4
More informationvol4.qxd09....04.20
CONTENTS Chapter 1 Section 1 Section 2 Section 3 Section 4 Section 5 Section 6 Section 7 Section 8 Chapter 2 Section 1 Section 2 Chapter1 Section 1 120 Chapter 1 121 Chapter 1 122 123 Chapter 1 Chapter
More informationコンテンツ・プロデュース機能の
CONTENTS Chapter 1 Section 1 Section 2 Section 3 Section 4 Section 5 Chapter 2 Section 1 Section 2 Section 3 Chapter 3 Section 1 Section 2 Section 3 Section 4 Section 5 Chapter 4 Section 1 Section 2 Section
More information02›f›æ’»“ì-16.qxd
Chapter 1 Section 1 Section 2 Chapter 2 Section 1 Section 2 Section 3 Section 4 CONTENTS Section 5 Section 6 Chapter1 Section 1 6 Chapter 1 7 Chapter 1 8 Chapter 1 Section 2 9 Chapter2 Section 1 10 Chapter
More informationコンテンツ・プロデュース機能の基盤強化に関する調査研究
CONTENTS Chapter 1 Section 1 Chapter 2 Section 1 Section 2 Section 3 Section 4 Section 5 Section 6 Section 7 Section 8 Chapter1 Section 1 6 Chapter 1 7 Chapter 1 8 Chapter 1 9 Chapter 1 10 11 Chapter
More informationJIS Z 9001:1998JIS Z 9002:1998 ISO/IEC 17025ISO/IEC Guide 25
JIS Q 17025 IDT, ISO/IEC 17025 IT JIS Z 9001:1998JIS Z 9002:1998 ISO/IEC 17025ISO/IEC Guide 25 JIS Q 17025 IDT, ISO/IEC 17025 IT IT JIS Q 17025ISO/IEC 17025 (2) JIS Z 9358 ISO/IEC Guide 58 (3) testing
More informationTaro12-認定-部門-ASG101-06
JIS Q 17025(ISO/IEC 17025(IDT)) JIS Q17025(ISO/IEC 17025(IDT)) --- --- JNLA JCSS ISO/IEC 17025 JIS Q 17025 IAJapan ILAC APLAC JIS Q17011 ISO/IEC 17011 MRA ILACAPLAC MRA IAJapan (3) JNLAJCSS (4) testing
More informationスライド 1
平成 24 年度 GMP 事例研究会平成 24 年 9 月 18 日 ( 東京 ) 9 月 21 日 ( 大阪 ) 米国 FDA 及び欧州 EMA による GMP 査察事例 塩野義製薬株式会社信頼性保証本部品質保証部小山靖人 1 本日の発表内容 本年 1 月 同一製造所 同一品目に対する 欧州 EMA(European Medicines Agency) と米国 FDA(Food and Drug
More information科技表紙PDF200508
2 1 2 20 Science & Technology Trends August 2005 21 3 22 Science & Technology Trends August 2005 23 4 24 C C Science & Technology Trends August 2005 25 C C C 26 5 Science & Technology Trends August 2005
More informationJapanese.PDF
2002 11 2 3 Part I 4 5 6 3.1WTO/TBT 2 3 6 3.2ISO/IEC 7 3.3 7 3.4 7 3.5 8 3.6 8 9 4.1 9 4.2 9 4.3 10 12 Part II 13 1.1 13 1.2 13 1.3 14 1.4 14 1.5 14 2 14 3 15 3.1 15 3.2 16 3.3 17 3.4 17 3.5 18 3.6 18
More informationインドシナ産業基板基礎調査団報告書
J R 01-08 ABBREVIATlON AOAC APEC APLAC APLMP APMP ASEAN ASTM BIPM BNM BOA BPS BS CBWM CGPM CMS CNLA CNS CSIR CSIRO DOE DOM DOST DSMQC DSN DSS DTI EMC ETL FAO GDP Association of Official Analytical Chemists
More informationuntitled
GLPGCP GLPGCP 16 915 335 300 EU GMP 2 B B GMP GMP H.5 GCP GCP H.2 H.9 H.15 H.17 GCP GCP / GCP GCP GCP GCP GCP GCPGCP 8 GCP GCPGCP 9 GCP GCPGCP 10 GCP GCP GCP GCP GLP LP GLP 3 4 6 FDA GVP Essential
More informationIFAC International Auditing Practice Committee Issued by the International Federation of Accountants
IFAC International Auditing Practice Committee Issued by the International Federation of Accountants Accounting estimate Accounting system Adverse opinion Agreed-upon procedures engagement Analytical
More information2014-sougou_all.pdf
19 Ministry of Health, Labour and Welfare 2014 Ministry of Health, Labour and Welfare 2014 20 21 Ministry of Health, Labour and Welfare 2014 Ministry of Health, Labour and Welfare 2014 22 23 Ministry of
More informationSolutions for Calibration & Maintenance ph / 6 GHS 2
Laboratory Solutions ph ORP / ISE / Solutions for Calibration & Maintenance ph / 6 GHS www.mt.com/buffer 2 5 Routine Operation 1 Evaluation 4 Qualification GEP TM 3 Installation 2 Selection Good Electrochemistry
More information208 2 1. 1998 2006 win-win 1990 3 1 2 3 1 2 3 1984 GM NUMMI New United Motor Manufacturing, Inc GM
2014 1. EMS Electronics Manufacturing Service EMS 2. 208 2 1. 1998 2006 win-win 1990 3 1 2 3 1 2 3 1984 GM NUMMI New United Motor Manufacturing, Inc GM 209 NUMMI UAW GM 2 2. 3. 2 3 1. 6 1 2 3 210 4 5 6
More informationContents 4 06 IP2 41 Thermo Scientific Nalgene Nalgene
Nalgene & Packaging plastic Bottles & Vials Contents 4 06 IP2 41 Thermo Scientific Nalgene 5 07 42 8 08 43 9 09 45 11 10 46 Nalgene 12 11 50 13 12 53 01 20 13 61 02 28 14 64 03 33 15 66 04 37 16 / 67 05
More informationMEISEI HEROES HERO HERO HERO MEISEI HEROES
MEISEI HEROES MEISEI HEROES HERO HERO HERO MEISEI HEROES 04 INDEX 06 28 08 24 26 10 14 16 22 18 20 MEISEI HEROES 05 04 MEISEI HEROES 2014 SCHOOL GUIDE MEISEI HEROES 1 2 3 4 5 06 MEISEI HEROES 2014 SCHOOL
More informationMacOSX印刷ガイド
3 CHAPTER 3-1 3-2 3-3 1 2 3 3-4 4 5 6 3-5 1 2 3 4 3-6 5 6 3-7 7 8 3-8 1 2 3 4 3-9 5 6 3-10 7 1 2 3 4 3-11 5 6 3-12 7 8 9 3-13 10 3-14 1 2 3-15 3 4 1 2 3-16 3 4 5 3-17 1 2 3 4 3-18 1 2 3 4 3-19 5 6 7 8
More information荳也阜轣ス螳ウ蝣ア蜻・indd
1 2 3 CHAPTER 1 4 CHAPTER 1 5 6CHAPTER 1 CHAPTER 1 7 8CHAPTER 1 CHAPTER 2 9 10CHAPTER 2 CHAPTER 2 11 12 CHAPTER 2 13 14CHAPTER 3 CHAPTER 3 15 16CHAPTER 3 CHAPTER 3 17 18 CHAPTER 4 19 20CHAPTER 4 CHAPTER
More informationはじめに レーザとは? 1) レーザ光の性質と特徴 補助資料 (1) 2) レーザ光による目の障害 補助資料 (2) IEC/EN の規格要求は? 3) レーザクラスと製造上の要求事項 補助資料 (3) 4) レーザクラス分けのための放射測定 補助資料 (4) 5) レーザ機器に表示す
レーザ規格への適合および申請方法の実際 [1]IEC/EN60825-1 規格要求に対する適合実務 [2]FDA レーザ規格への適合と申請方法 お断り : 本セミナーでご紹介しています実務レーザレポート 及びその関連資料は製造メーカー様のご了解を得てその情報を開示させていただいております Copyright 2007, FSS Corporation 1 はじめに レーザとは? 1) レーザ光の性質と特徴
More informationuntitled
13,000 1 35,400 8,000 1 35,400 2 ~6 46,000 2 ~6 46,000 7 55,000 7 55,200 2,750 2,750 4,910 4,910 149,000 149,000 45,000 75,000 45,000 75,000 189,000 165,400 151,200 132,300 33 29 4 33 29 4 150,410 128,100
More information/
333 344 / 332 03-6264-066003-6264-0663 03-6264-0620 334 LAL 335 336 LAL 338 QCL-1000 LAL 33 LAL 340 C 341 LAL 343 ELx808 344 FLx800 345 PyroTec 346 WinKQCL 347 CSE 348 / 03-6264-066003-6264-0663 03-6264-0620
More information< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS
< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic
More informationGUIDE BOOK 2012 Social Cooperation Career Improvement and Certificate Career Improvement and Certificate Humanity and Society Humanity and Society Nature and Science Nature and Science Information
More informationPipet-Lite XLS Pipet-Lite XLS XLS+ RFID LTS 2 LTS LTS RFID XLS+
Pipet-Lite XLS+ RFID Pipet-Lite XLS Pipet-Lite XLS XLS+ RFID LTS 2 LTS LTS RFID 1.1... 3 1.2... 4 1.3... 6 1.4... 6 1.5... 7 1.6... 8 1.7... 8 1.8... 8 1.9... 10 1.10 XLS+... 10 1.11... 11 1.12... 11 1.13...
More information1 May 2011
1 May 2011 2 May 2011 3 May 2011 4 May 2011 5 June 2011 6 June 2011 7 June 2011 8 June 2011 9 July 2011 10 July 2011 11 July 2011 12 July 2011 13 August 2011 14 August 2011 15 August 2011 16 August 2011
More information2013 Vol.62 No.6 p.617 624 Use of cost-effectiveness evaluation in local government administration in cancer screening: from the perspective of someone who competes to secure budget Masahiko KANNO Adult
More informationJPMA Activity for Data Integrity GMP Discussion Forum (2017) Role and Responsibility of QC-Lab. - Laboratory control including Data Integrity - GMP Ca
Data Reliability of QC-Lab. Japan Pharmaceutical Manufacturers Association (JPMA) Quality & Technology Committee Hiroshi Fujie 1 JPMA Activity for Data Integrity GMP Discussion Forum (2017) Role and Responsibility
More informationPrimer_AIQ_cover_JAJP_Umschlag_Primer_AIQ_final.qxd
USP 入門書 21 CFR Part 11 GxPcGMP PIC/S SOP ISO 17025 QA/QC DQ GLPOQIQ ICH PQ FDA OECD GCP 分析機器の適格性評価と システムのバリデーション 分析機器の適格性評価とシステムのバリデーション Ludwig Huber 目次序文...............................................
More information09_理学部案内S2.indd
Okayama University Faculty of Science Okayama University Faculty of Science 2009 1 2 4 6 10 14 18 22 26 27 28 29 30 32 34 36 37 CONTENTS Okayama University Faculty of Science 1 Okayama University Faculty
More informationfl™‹ä1.eps
Information Science Japan Advanced Institute of Science and Technology, Announcement of Researchers School of Information Science Shirai Laboratory Research Interests Associate Professor Kiyoaki Shirai
More informationJP.qxd
Agilent 2100 1 DNA RNA Lab-on-a-Chip Agilent 2100 1999 Agilent 2100 Lab-on-a-Chip Agilent 2100 RNA DNA SDS-PAGE Agilent 2100 Agilent 2100 Agilent 2100 : (1 4 µl) 30 21 CFR Part 11 Agilent 2100 Agilent
More information2 1. 3 2. 4 3. 4 4 5 6 / 7 4. ph 8 5. 10 6. 10 7. 10 Ti-Note Food & Beverage No. 06 11 Ti-Note Food & Beverage No. 07 13 Ti-Note Food & Beverage No. 0
Food & Beverage Analysis p 2 1. 3 2. 4 3. 4 4 5 6 / 7 4. ph 8 5. 10 6. 10 7. 10 Ti-Note Food & Beverage No. 06 11 Ti-Note Food & Beverage No. 07 13 Ti-Note Food & Beverage No. 08 15 Ti-Note Food & Beverage
More information...a.T.X 04_PDF.p
2004 Sustainable Focus DAAM P19 P32 P42 P19 P41 P18 P16-17 P22 P23 4 21 KYOWA BIO-INNOVATOR 1. 2. 3. 4. 5. 6. 7. 8. 9. Kyowa Hakko Group s Sustainability Universe OUT CO2 SOx NOx IN OUT 2 MR IN OUT CONTENTS
More information制度から見る薬剤師の役割
平成 27 年 7 月 23 日第 32 回 ICH 即時報告会全電通労働会館 ( 全電通ホール ) ICH Q12: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management 医薬品医療機器総合機構 再生医療製品等審査部 岸岡康博 1 本日の内容 本トピックの目的 リスボン会議後から福岡会議までの活動
More information損保ジャパンの現状2011
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 62 63 64 65 66 67 68 69
More informationContents ph
perfection Guidebook perfection Comb Ag/S Contents 1. 1 2. 2 3. 5 5 7 8 9 11 14 4. 16 18 18 22 25 31 33 37 37 41 43 5. 47 47 48 48 49 ph 50 50 51. 6. 53 55 7. 59 8. 61 Introduction 1. / ISE / Ag 2 S /
More informationResearch on Academic Degrees and University Evaluation The Chronicle of Higher Education Chronicle Analytical Perspectives Research Centers Directory Research Centers Directory Administrative Policies
More information596_H1H4.indd
2014 Aug. 8No.596 http://www.saitama-ctv-kyosai.net 1021 1125 1127 10 10 27 11 11 17 11 11 20 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
More informationuntitled
c Society5.0 Society5.0 Society5.0 Society5.0 2017 Society5.0 SDGs SIP PRISM Society5.0 2017 SIP ImPACT PRISM SDGs 1. Society5.0 2016 9 Society5.0 OR [1] Society5.0 2. Society5.0 2.1 Society5.0 Society5.0
More informationLC ACQUITY UPLC H-Class Bio TUV Sigma, mg/ml 0.01 N 276 nm μl 0.4 ml/min L g/l / 99% / 65/15/20 v/v/v 10% 10% 0.01 N ACQUITY
Ultra Performance Liquid Chromatography Stephan Koza, Paula Hong, and Kenneth J. Fountain Waters Corporation, 34 Maple Street, Milford, MA, USA & SEC 2010 2 8 5 2030 4 3 8 1982 2009 131 USP EPHMW USP34
More informationCEO 2017.10.30 Agenda Agenda ) 2000 2000 10 ~ ~ GLP: Good Laboratory Practice GCP: Good Clinical Practice GMP: Good Manufacturing Practice GPSP: Good Post-marketing Study 1 10,000 Practice GLP GMP GCP
More information/toushin/.htm GP GP GP GP GP p.
GP GP GP http://www.mext.go.jp/b_menu/shingi/chukyo/chukyo /toushin/.htm GP http://www.mext.go.jp/a_menu/koutou/kaikaku/yousei.htm GP GP GP GP p. GP pp. - :p.p.,:p. critical thinking GP HP GP GP GP GP
More informationMicrosoft Word - 表紙資料2-4
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
More information33312004_先端融合開発専攻_観音0314PDF用
Advanced Course for Interdisciplinary Technology Development National Institute of Technology, Gifu College Advanced Course for Interdisciplinary Technology Development 1 5 Curriculum National Institute
More informationOECD (
2.1.1 1991 3 2002 2 2004 7 2003 1,684 / 316 / 65 / 938 / 302 / 2008 2010 30 2-1 0506.9010 OECD ( 2619.0000 4401.3000 4501.9000 4707.1000 4707.2000 4707.3000 4707.9000 5202.1000 5202.9900 5505.1000 5505.2000
More informationGMP
GMP E U G M P G o o d Manufacturing Practice quality-by-test quality-by-design GMP GMP GMP / 140 2 ヴァイサラでは 倉庫や規定された保管施設でのマッピングを適切に行うため 以下の9つのプロセスを推奨しています 1. バリデーションプランの策定 2. リスクエリアの特定 3. プロトコル情報の作成 4.
More information< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS
< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic
More information資料2
OECD GLP OECD OECD 1960 30 OECD TG 2001 10 17 8 TG 202 208 TG 201 1984 6 TG 202 1984 4 TG 202 2000 10 TG 203 1992 7 TG 204 14 1984 4 TG 205 1984 4 TG 206 1984 4 TG 207 1984 4 TG 208 1984 4 2000 TG 209
More informationSI SI CIPM MRA
JAB RL331-2008 2008 11 1 2008 9 1 2008-09-01-1/25-1 2008-11-01 ... 3... 3... 4 3.1...4 3.2...4... 5... 7... 8 6.1...8 6.1.1 SI...8 6.1.2 SI...9 6.2...9 6.3...9 6.4...10... 10 7.1 CIPM MRA...10 7.2 135...11
More informationbac2017_00_15
2017 Faculty of Bioscience and Applied Chemistry Department of Frontier Bioscience Department of Chemical Science and Technology Department of Clinical Plant Science TEL:03-3264-9300 http://www.hosei.ac.jp/
More information2671026 7 1515 800 D 16551659 2 350 15 10 15 131817 2014.August No.800 8 16 26 6 2612 8 9 1 400 26 9 1227 3 3 4,800 5 6 8 9 1 7 8 11 800 800 800 10 26 15 20 24 26 28 29 30 31 32 6 7 8 9 10 11 12 1 26
More informationuntitled
http://www.ecompliance.co.jp 1.0 2006/05/26 1.1 2006/07/24 1.2 2007/03/28 Copyright(C) 2006 ecompliance Ltd. All Rights Reserved. 1....1 2....1 2.1...1 2.2...1 3....1 3.1...1 3.2...1 3.3...1 3.4...1 3.5...1
More informationAutomatic analyzer for clinical chemistry
225 226 5.1.1 1 Automatic analyzer for clinical chemistry 227 5.1.1 2 228 5.1.2.1 Clinical spectrophotometer 5.1.3 Electrolyte analyzer 229 230 5.1.4 Electrophoresis apparatus 231 BF 5.1.5 1 Immunoassay
More informationMicrosoft PowerPoint - ○Lab1-intro-07-JPN-英日.pptx
Introduction GMP Compliance for Quality Control Laboratory Operations 2007 PharmaNet, Inc. 品質管理試験室作業の GMP 遵守 2007 PharmaNet, Inc. Page Intro-1 1994, 1997, 1999, 2000, 2002, 2004, 2006 Introduction Laboratory
More informationMicrosoft PowerPoint - PCG-AssessmentReportSummary (J) v2.0d3.pptx
PCG Solutions / Viedoc 供給者アセスメント報告書のご紹介 2017 年 8 月アズビル株式会社 はじめに アズビルは ( スポンサからの委託に依らず ) 独自にPCG Solutions AB( 以下 PCG Solutions) に対してサプライヤアセスメントを実施しました このアセスメント結果をまとめた PCG Solutions / Viedoc 供給者アセスメント報告書
More information1 48
Section 2 1 48 Section 2 49 50 1 51 Section 2 1 52 Section 2 1 53 1 2 54 Section 2 3 55 1 4 56 Section 2 5 57 58 2 59 Section 2 60 2 61 Section 2 62 2 63 Section 2 3 64 Section 2 6.72 9.01 5.14 7.41 5.93
More informationSection 1 Section 2 Section 3 Section 4 Section 1 Section 3 Section 2 4 5 Section 1 6 7 Section 1 8 9 10 Section 1 11 12 Section 2 13 Section 2 14 Section 2 15 Section 2 16 Section 2 Section 2 17 18 Section
More informationJAB RL JAB RL358: XX
1 2 3 4 5 6 7 8 9 JAB RL358: -20082013 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 2 2013 8 XX 1 2008 2 1 29 30 31 32 33 2008-02-01-1/28-2 2013-07-XX 34 35 36 37 38 39 40 41 42 43 44 45 46
More information